Just In
HCL FY26 Guidance: Revenue growth expected to be between 3.0%-5.0% YoY in CC
HCL reported revenue of $3,545 million in USD terms, marking a 1.3% increase QoQ and 5.4% growth YoY
HCL's revenue in constant currency declined 0.8% quarter-on-quarter but grew 3.7% year-on-year
HCL FY26 Guidance: Revenue growth expected to be between 3.0%-5.0% YoY in CC
HCL reported revenue of $3,545 million in USD terms, marking a 1.3% increase QoQ and 5.4% growth YoY
HCL's revenue in constant currency declined 0.8% quarter-on-quarter but grew 3.7% year-on-year

pharmaceutical industry

(17 search results)

Pharma stocks fall up to 7% as Trump promises to slash US drug prices by 30% to 80%
India's pharmaceutical industry poised for global leadership: McKinsey report
China's API extortion from Indian pharma breaking down
Centre to review medicine price regulation norms soon
New rules bar unethical marketing by pharma companies
Akums Drugs and Pharmaceuticals Limited: Endeavour to deliver Quality Medicines and Advancing Pharmaceutical Manufacturing
Piramal Pharma shares rise 8% after Q2 results
Pharma's Richest Ride Demand Tailwinds
New scheme for R&D in pharma, medtech
Medical device makers wary of new Bill to regulate drugs, devices and cosmetics